Follow the latest coverage, related explainers and connected technology stories.
Oura filed for an initial public offering that could be worth up to $2.2 billion, offering 50 million shares at an estimated price of between $40 and $44 per share. The offering comes as the company expands its health features, while facing regulatory questions and a proposed lawsuit concerning the accuracy of sleep tracking.
The Centers for Medicare and Medicaid Services is expanding the ACCESS program to include heart failure, chronic obstructive pulmonary disease, substance use disorders, and smoking cessation, while extending support for certain musculoskeletal conditions. The program combines outcome-linked payments with a regulatory pathway for collecting real-world data on certain digital health technologies.